Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shortening Buruli Ulcer Therapy with Amoxicillin/Clavulanate
NCT05169554Phase 2Recruiting
- Sponsor
- ARAID
- Start
- Dec 2021
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of amoxicillin + clavulanate in Buruli ulcer (BU), sponsored by ARAID. Started Dec 2021; status: recruiting.
02
Drugs
amoxicillin + clavulanate
03
Conditions
Buruli ulcer (BU)
Beyond the preview
Go deeper on NCT05169554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05169554.